BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28621237)

  • 21. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
    Kato M; Kitayama J; Kazama S; Nagawa H
    Breast Cancer Res; 2003; 5(5):R144-50. PubMed ID: 12927045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression Patterns of CXCL12 and its Receptor in Colorectal Carcinoma.
    Mousavi A; Hashemzadeh S; Bahrami T; Estiar MA; Feizi MAH; Pouladi N; Rostamizadeh L; Sakhinia E
    Clin Lab; 2018 May; 64(5):871-876. PubMed ID: 29739049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer.
    Yoshitake N; Fukui H; Yamagishi H; Sekikawa A; Fujii S; Tomita S; Ichikawa K; Imura J; Hiraishi H; Fujimori T
    Br J Cancer; 2008 May; 98(10):1682-9. PubMed ID: 18443596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
    Wang P; Liang J; Wang Z; Hou H; Shi L; Zhou Z
    Tumour Biol; 2017 May; 39(5):1010428317703651. PubMed ID: 28468582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
    Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.
    Zheng F; Zhang Z; Flamini V; Jiang WG; Cui Y
    Anticancer Res; 2017 Aug; 37(8):4361-4369. PubMed ID: 28739729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
    Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
    Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
    Wang H; Xie F; Hu Z; Chen L
    Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
    Chen Q; Zhong T
    Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vascular CXCR4 expression in colorectal carcinoma.
    Ingold B; Schulz S; Budczies J; Neumann U; Ebert MP; Weichert W; Röcken C
    Histopathology; 2009 Nov; 55(5):576-86. PubMed ID: 19912363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
    Iwasa S; Yanagawa T; Fan J; Katoh R
    Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma.
    Wu Z; Han X; Yan J; Pan Y; Gong J; Di J; Cheng Z; Jin Z; Wang Z; Zheng Q; Wang Y
    Biomed Pharmacother; 2012 Jul; 66(5):373-7. PubMed ID: 22401929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer.
    Nagasawa S; Tsuchida K; Shiozawa M; Hiroshima Y; Kimura Y; Hashimoto I; Watanabe H; Kano K; Numata M; Aoyama T; Sato S; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Morinaga S; Yukawa N; Rino Y; Masuda M; Saeki H; Miyagi Y; Oshima T
    Anticancer Res; 2021 Sep; 41(9):4489-4495. PubMed ID: 34475074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.